» Articles » PMID: 23922807

Circulating MiRNA Biomarkers for Alzheimer's Disease

Overview
Journal PLoS One
Date 2013 Aug 8
PMID 23922807
Citations 172
Authors
Affiliations
Soon will be listed here.
Abstract

A minimally invasive diagnostic assay for early detection of Alzheimer's disease (AD) is required to select optimal patient groups in clinical trials, monitor disease progression and response to treatment, and to better plan patient clinical care. Blood is an attractive source for biomarkers due to minimal discomfort to the patient, encouraging greater compliance in clinical trials and frequent testing. MiRNAs belong to the class of non-coding regulatory RNA molecules of ∼22 nt length and are now recognized to regulate ∼60% of all known genes through post-transcriptional gene silencing (RNAi). They have potential as useful biomarkers for clinical use because of their stability and ease of detection in many tissues, especially blood. Circulating profiles of miRNAs have been shown to discriminate different tumor types, indicate staging and progression of the disease and to be useful as prognostic markers. Recently their role in neurodegenerative diseases, both as diagnostic biomarkers as well as explaining basic disease etiology has come into focus. Here we report the discovery and validation of a unique circulating 7-miRNA signature (hsa-let-7d-5p, hsa-let-7g-5p, hsa-miR-15b-5p, hsa-miR-142-3p, hsa-miR-191-5p, hsa-miR-301a-3p and hsa-miR-545-3p) in plasma, which could distinguish AD patients from normal controls (NC) with >95% accuracy (AUC of 0.953). There was a >2 fold difference for all signature miRNAs between the AD and NC samples, with p-values<0.05. Pathway analysis, taking into account enriched target mRNAs for these signature miRNAs was also carried out, suggesting that the disturbance of multiple enzymatic pathways including lipid metabolism could play a role in AD etiology.

Citing Articles

Preclinical Alzheimer's disease shows alterations in circulating neuronal-derived extracellular vesicle microRNAs in a multiethnic cohort.

Reho P, Kalia V, Jackson G, Wang F, Eiten E, Brennan K Alzheimers Dement. 2025; 21(3):e70050.

PMID: 40042514 PMC: 11881609. DOI: 10.1002/alz.70050.


Newer Therapeutic Approaches in Treating Alzheimer's Disease: A Comprehensive Review.

Reddi Sree R, Kalyan M, Anand N, Mani S, Gorantla V, Sakharkar M ACS Omega. 2025; 10(6):5148-5171.

PMID: 39989768 PMC: 11840625. DOI: 10.1021/acsomega.4c05527.


Second-generation anti-amyloid monoclonal antibodies for Alzheimer's disease: current landscape and future perspectives.

Kim B, Kim S, Nam Y, Park Y, Shin S, Moon M Transl Neurodegener. 2025; 14(1):6.

PMID: 39865265 PMC: 11771116. DOI: 10.1186/s40035-025-00465-w.


Selective diagnostics of Amyotrophic Lateral Sclerosis, Alzheimer's and Parkinson's Diseases with machine learning and miRNA.

Lee J, Kouznetsova V, Kesari S, Tsigelny I Metab Brain Dis. 2025; 40(1):79.

PMID: 39747792 DOI: 10.1007/s11011-024-01490-w.


Biofluid biomarkers for Alzheimer's disease: past, present, and future.

An C, Cai H, Ren Z, Fu X, Quan S, Jia L Med Rev (2021). 2024; 4(6):467-491.

PMID: 39664082 PMC: 11629312. DOI: 10.1515/mr-2023-0071.


References
1.
Tapiola T, Alafuzoff I, Herukka S, Parkkinen L, Hartikainen P, Soininen H . Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol. 2009; 66(3):382-9. DOI: 10.1001/archneurol.2008.596. View

2.
Hebert S, Horre K, Nicolai L, Papadopoulou A, Mandemakers W, Silahtaroglu A . Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci U S A. 2008; 105(17):6415-20. PMC: 2359789. DOI: 10.1073/pnas.0710263105. View

3.
McGuinness B, Passmore P . Can statins prevent or help treat Alzheimer's disease?. J Alzheimers Dis. 2010; 20(3):925-33. DOI: 10.3233/JAD-2010-091570. View

4.
Thambisetty M, Simmons A, Hye A, Campbell J, Westman E, Zhang Y . Plasma biomarkers of brain atrophy in Alzheimer's disease. PLoS One. 2011; 6(12):e28527. PMC: 3244409. DOI: 10.1371/journal.pone.0028527. View

5.
Gupta A, Nagilla P, Le H, Bunney C, Zych C, Thalamuthu A . Comparative expression profile of miRNA and mRNA in primary peripheral blood mononuclear cells infected with human immunodeficiency virus (HIV-1). PLoS One. 2011; 6(7):e22730. PMC: 3145673. DOI: 10.1371/journal.pone.0022730. View